Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer
A new international study led by Monash University has, for the first time, identified that beta-blockers could significantly enhance the therapeutic effect of anthracycline chemotherapy in triple negative breast cancer (TNBC) ...